NFlection Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
867 Boylston St Fl 5, Boston, Massachuse...Website
www.nflection.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About NFlection Therapeutics
We are initially focused on the treatment of cutaneous neurofibromas in neurofibromatosis type 1, disfiguring congenital birthmarks (including keratinocytic epidermal nevi and nevus sebaceous), and the prevention of immunosuppressant-mediated squamous cell carcinoma. We are funded by F-Prime Capital, venBio, and the Children's Tumor Foundation and have assembled a proven team of experienced drug development professionals and key opinion leaders to develop a "soft" (metabolically labile) topical MEK inhibitor to treat disfiguring RAS-mediated conditions of the skin. NFlection Therapeutics logoExplore more
NFlection Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NFlection Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NFlection Therapeutics launches new products
NFlection Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NFlection Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at NFlection Therapeutics
Click to see if NFlection Therapeutics had a recent Job posting/layoffs
Check out if NFlection Therapeutics is spiking on competitors!
Earning: See what the market has to say on NFlection Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once NFlection Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to NFlection Therapeutics
Compare insights from companies similar to NFlection Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NFlection Therapeutics Tech Stack
A closer look at the technologies used by NFlection Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NFlection Therapeutics
Sign Up For FreeTo access detailed company insights
We are initially focused on the treatment of cutaneous neurofibromas in neurofibromatosis type 1, disfiguring congenital birthmarks (including keratinocytic epidermal nevi and nevus sebaceous), and the prevention of immunosuppressant-mediated squamous cell carcinoma. We are funded by F-Prime Capital, venBio, and the Children's Tumor Foundation and... Read More
